REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Aurancia Kft. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: AURANCIA Gyogyszertar Kft. Profile Updated: July 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

Aurancia Kft. is based in Hungary, with the head office in Budapest. The enterprise currently operates in the Pharmacies and Drug Stores sector. The company was established on June 12, 2007. It currently has a total number of 6 (2024) employees. In 2023, the company reported a net sales revenue increase of 8.49%. Its’ total assets recorded a growth of 15.46%. Aurancia Kft.’s net profit margin increased by 4.41% in 2023.

Headquarters
Arpad ut 77.
Budapest; Budapest; Postal Code: 1042

Contact Details: Purchase the Aurancia Kft. report to view the information.

Website: http://www.jokaibiocentrum.hu

Basic Information
Total Employees:
Purchase the Aurancia Kft. report to view the information.
Outstanding Shares:
Purchase the Aurancia Kft. report to view the information.
Registered Capital:
Purchase the Aurancia Kft. report to view the information.
Financial Auditors:
Purchase the Aurancia Kft. report to view the information.
Incorporation Date:
June 12, 2007
Key Executives
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
Jokai Biocentrum Kft.
Company Performance
Financial values in the chart are available after Aurancia Kft. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
8.49%▲
Total operating revenue
8.76%▲
Operating profit (EBIT)
165.12%▲
EBITDA
146.06%▲
Net Profit (Loss) for the Period
62.8%▲
Total assets
15.46%▲
Total equity
17.31%▲
Operating Profit Margin (ROS)
8.87%▲
Net Profit Margin
4.41%▲
Return on Equity (ROE)
5.06%▲
Quick Ratio
-0.27%▼
Cash Ratio
-0.03%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo